论文部分内容阅读
目的:分析加替沙星与盐酸氨溴索雾化吸入对老年急性肺炎患者的临床疗效及安全性。方法:采用对比研究的方法,选取2014年3月—2016年1月间收治的急性肺炎老年患者186例,将其分为治疗组和对照组,每组93例;治疗组患者均给予加替沙星与盐酸氨溴索雾化吸入治疗,对照组患者均给予静脉滴注加替沙星治疗,评价两组患者治疗后的总有效率和安全性。结果:治疗组患者治疗后的总有效率为90.32%明显高于对照组为68.82%(P<0.05);治疗过程中不良反应的发生率为9.68%低于对照组为23.66%(P<0.05)。结论:采用加替沙星与盐酸氨溴索雾化吸入治疗老年急性肺炎患者的临床疗效,优于单用加替沙星的疗效。
Objective: To analyze the clinical efficacy and safety of inhalation of gatifloxacin and ambroxol hydrochloride inhalation for senile patients with acute pneumonia. Methods: A comparative study of 186 elderly patients with acute pneumonia admitted from March 2014 to January 2016 was selected and divided into treatment group and control group, 93 cases in each group. Patients in the treatment group were given replacement Shaoxing and ambroxol hydrochloride atomization inhalation therapy, patients in the control group were given intravenous infusion of gatifloxacin to evaluate the two groups of patients after treatment, the total efficiency and safety. Results: The total effective rate of the treatment group was 90.32%, which was significantly higher than that of the control group (68.82%, P <0.05). The incidence of adverse reactions was 9.68% in the treatment group and 23.66% in the control group (P <0.05) ). Conclusion: Gatifloxacin and ambroxol hydrochloride inhalation in the treatment of elderly patients with acute pneumonia clinical efficacy, superior to gatifloxacin alone.